Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine neuroprotection during meningioma resection
ChiCTR-IPR-15006498Phase 4Recruiting
- Sponsor
- The Affiliated Hospital of Qingdao University
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine in meningioma (2 arms), sponsored by The Affiliated Hospital of Qingdao University. Primary endpoints: Neuron-specific enolase, S100beta protein and 4 more. Started Jun 2015; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
meningioma
Beyond the preview
Go deeper on ChiCTR-IPR-15006498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15006498.